tiprankstipranks
Trending News
More News >

Dev Prasad Profile - Lucid Capital Analyst

32 Followers
tipranks
Dev Prasad

Dev Prasad
Lucid Capital

Wall Street Analyst
#2,188 out of 10,113 Wall Street Analysts
#5,710 out of 42,320 experts

Success Rate

64%
7 out of 11 ratings made a profit

Average Return

+37.30%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Dev Prasad's trades since 2024 and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of 37.3% per rating.

Stock Rating Distribution

12Ratings
91.67% Buy
8.33% Hold
0.00% Sell
Distribution of Dev Prasad's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States
Canada

Best Rating

Stock:
Palvella Therapeutics, Inc.
(PVLA)
Rating:Buy
Date:Mar 18, 2025 - Today
Return:+228.50%
The most profitable rating made by Dev Prasad

Dev Prasad's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Ibio
Dec 17, 2024
Buy
Initiated
$6.00
(387.80% Upside)
1Ratings
0%
-58.80%
Avalo Therapeutics
Dec 17, 2024
Buy
Initiated
$24.00
(26.32% Upside)
1Ratings
100%
+89.10%
CalciMedica
Dec 17, 2024
Buy
Initiated
$13.00
(204.45% Upside)
1Ratings
100%
+13.60%
Palvella Therapeutics
Mar 18, 2025
Buy
Initiated
$49.00
(-52.33% Downside)
1Ratings
100%
+228.50%
Aligos Therapeutics
May 01, 2025
Buy
Initiated
$36.00
(275.78% Upside)
1Ratings
100%
+36.80%
Edesa Biotech
May 23, 2025
Buy
Initiated
$9.00
(414.29% Upside)
1Ratings
0%
-11.70%
Opus Genetics
Jun 17, 2025
Buy
Initiated
$5.00
(134.74% Upside)
1Ratings
100%
+109.10%
Cue Biopharma
Aug 25, 2025
Buy
Initiated
$4.00
(534.92% Upside)
1Ratings
0%
-33.90%
aTyr Pharma
Sep 15, 2025
Hold
Downgraded
$1.00
(28.12% Upside)
1Ratings
0.00%
Medicenna Therapeutics Corp
Oct 14, 2025
Buy
Initiated
C$4.00
(150.00% Upside)
1Ratings
100%
+48.90%
List of latest recommendations made by Dev Prasad. Click to expand and see Dev Prasad's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Dev Prasad activity FAQ

What is the performance of Dev Prasad's recommendations?
The percentage of profitable recommendations made by Dev Prasad is 64%, and the average return per transaction is 37.30%.
    What stocks does Dev Prasad cover?
    Dev Prasad mostly covers IFRX ,VRCA ,TSE:MDNA stocks.
      What was Dev Prasad's most profitable rating?
      Dev Prasad’s most profitable ratings was a buy on PVLA stock on Mar 18, 2025 - Today. The return on the trade was +228.50%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here